Ling, V., Marlton, P., Reynolds, J., Dawson, M., Gasiorowski, R., Rose, H., Fong, C. Y., Shortt, J., Enjeti, A., Grove, C., Nkyekyer, J., Munsef, N., Wei, A. (2025). Trial in progress: A Phase IIb randomized clinical trial combining oral azacitidine and vididencel, a novel immunotherapy, for post-remission / maintenance therapy for adult patients with cytogenetically intermediate and high-risk Acute Myeloid Leukemia (ALLG AMLM22/D4 CADENCE). Blood. https://doi.org/10.1182/blood-2025-5210